Calcium Levulinate

Calcium levulinate is a calcium salt of levulinic acid, a short-chain keto acid derived from cellulose, delivering elemental calcium alongside a metabolically active organic anion. It dissociates in aqueous solution to release Ca²⁺ ions and levulinate, which may facilitate intestinal calcium transport via solubility-driven passive diffusion.

Origin & History

Calcium levulinate is a calcium salt of levulinic acid formed by direct reaction between levulinic acid and calcium hydroxide, existing as either anhydrous crystals or dihydrate granular powder. Levulinic acid derives from biomass sources like sugars, though specific extraction methods beyond chemical synthesis are not detailed in available research.

Historical & Cultural Context

No historical or traditional medicine uses for calcium levulinate are documented in available research. The compound appears to be a modern pharmaceutical preparation without established traditional applications.

Health Benefits

• Provides bioavailable calcium with 14.8% higher calcium content than calcium lactate (preliminary evidence)
• Non-toxic and non-allergenic profile suitable for sensitive individuals (safety data only)
• High solubility (>30% at 25°C) may support better absorption than other calcium forms (theoretical benefit)
• Neutral pH (~7) with minimal irritation potential for digestive comfort (safety profile)
• Good stability prevents precipitation in formulations (pharmaceutical characteristic)

How It Works

Calcium levulinate dissociates in gastrointestinal fluid to free Ca²⁺ ions and levulinate anions; the high aqueous solubility (greater than 30% w/v at 25°C) keeps calcium ionized at intestinal pH, favoring passive paracellular absorption between enterocytes. Active transcellular uptake engages TRPV6 calcium channels on the apical membrane of duodenal enterocytes, with subsequent transport by calbindin-D9k and basolateral extrusion via the PMCA1b pump. The levulinate moiety enters the tricarboxylic acid cycle as a ketone precursor, though its direct contribution to calcium transport enhancement remains theoretical rather than clinically confirmed.

Scientific Research

No human clinical trials, RCTs, or meta-analyses examining calcium levulinate's efficacy have been identified in available sources. The research consists primarily of chemical characterization and pharmaceutical properties rather than clinical outcome studies.

Clinical Summary

Direct clinical trials on calcium levulinate supplementation in humans are largely absent from the peer-reviewed literature, limiting conclusions about efficacy to mechanistic and comparative chemistry data. Comparative solubility studies indicate calcium levulinate dissolves at greater than 30% concentration at 25°C, substantially exceeding calcium carbonate (0.0013%) and calcium citrate (0.085%), which theoretically supports superior bioavailability under low-gastric-acid conditions. One preliminary in vitro dataset suggests approximately 14.8% higher elemental calcium delivery per gram compared to calcium lactate, though this has not been validated in pharmacokinetic absorption studies with human subjects. Overall, evidence quality is preclinical and mechanistic; robust randomized controlled trials with fracture, bone-density, or serum-calcium endpoints are needed before definitive efficacy claims can be made.

Nutritional Profile

Calcium Levulinate (C10H14CaO6) is a calcium salt of levulinic acid with a molecular weight of 306.32 g/mol. Elemental calcium content: approximately 13.1% by weight (meaning ~131 mg calcium per 1g of calcium levulinate), which is notably higher than calcium lactate (~13.0%) but lower than calcium carbonate (~40%). The levulinate anion (C5H7O3-) constitutes the remaining ~86.9% of molecular weight and is derived from levulinic acid, a short-chain keto-acid. Contains no protein, fiber, fat, or carbohydrates in the conventional nutritional sense. The levulinate moiety is a 5-carbon oxo-acid that may participate in basic metabolic pathways, though its metabolic contribution at supplemental doses is considered negligible. Solubility exceeds 30% w/v at 25°C, which is substantially higher than calcium carbonate (<0.1%) and calcium citrate (~0.1%), theoretically supporting dissolution in gastrointestinal fluid prior to absorption. Bioavailability data is limited compared to calcium citrate or calcium carbonate; the high solubility suggests good ionization at intestinal pH, but direct human bioavailability trials are sparse. No significant vitamin content. Mineral content is exclusively calcium. pH of aqueous solution is approximately neutral (6.5–7.5), which minimizes gastric acid buffering effects that reduce absorption seen with carbonate forms.

Preparation & Dosage

No clinically studied dosage ranges or standardized forms have been established for calcium levulinate supplementation. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Calcium lactate, Calcium chloride, Vitamin D3, Magnesium, Vitamin K2

Safety & Interactions

Calcium levulinate is considered non-toxic at supplemental doses, with safety profiles extrapolated from its component ions; levulinic acid is classified as generally recognized as safe (GRAS) by the FDA at food-use concentrations. Like all calcium salts, high doses (above 2,500 mg elemental calcium per day) carry risk of hypercalcemia, nephrolithiasis, and constipation, and it should be used cautiously in individuals with hypercalciuria or renal insufficiency. Calcium ions can chelate tetracycline and fluoroquinolone antibiotics, reducing their absorption by up to 50%, and may interfere with iron and zinc absorption when co-administered; a 2-hour separation is recommended. Pregnancy and lactation safety has not been specifically studied for calcium levulinate, though calcium supplementation generally is considered safe in pregnancy at doses meeting the recommended dietary allowance of 1,000–1,300 mg elemental calcium daily.